HELP Therapeutics Co., Ltd.
HELP Therapeutics Co., Ltd.
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HiCM-188 Cell Therapy in Adults With Advanced Heart Failure Undergoing Heart Bypass Surgery | advanced heart failure | Not yet recruiting | Phase 1 / Phase 2 | 2026-06-29 | NCT07646210 | |
| A Pivotal Clinical Trial of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes Injection (HiCM-188) for the Treatment of Advanced Heart Failure(NYHA III-IV) | cardiovascular disorder, heart disorder, heart failure | Recruiting | Phase 3 | 2026-05-12 | NCT07496372 | |
| hiPSC-CMs-loaded Chitosan Patch to Treat Severe Chronic Ischemic Heart Disease | CABG-patients; Ischemic Heart Failure | Not yet recruiting | Phase 1 / Phase 2 | 2026-03-13 | NCT07471698 | |
| Intravenous Infusion of Human Mesenchymal Stem Cells (HMM910 ) in Postmenopausal Women With Osteoporosis at High Risk of Fracture | Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, bone disorder, bone fracture, injury, metabolic disease, musculoskeletal system disorder, osteoporosis | Active, not recruiting | Phase 1 | 2026-02-10 | NCT06949137 | |
| Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Phase 1 / Phase 2 | 2026-02-10 | NCT06340048 | |
| IPSC-CMs Combined with LVAD or CABG for the Treatment of Heart Failure | cardiovascular disorder, heart disorder, heart failure | Not yet recruiting | Phase 1 / Phase 2 | 2025-03-14 | NCT06866600 |